Showing results (651-660 of 1,794) with videos related to
Sort By:
Pageof 180
Mabs|November 29, 2017
Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responsesBoning Liu, Huaizu Guo, Jin Xu, et al.Mabs|December 15, 2017
Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27-28, 2017, Tours, FranceCamille Martin, Claire Kizlik-Masson, André Pèlegrin, et al.Mabs|September 22, 2017
Epitope characterization of anti-JAM-A antibodies using orthogonal mass spectrometry and surface plasmon resonance approachesGuillaume Terral, Thierry Champion, François Debaene, et al.Mabs|September 13, 2017
Preclinical pharmacokinetic characterization of an adipose tissue-targeting monoclonal antibody in obese and non-obese animalsSharmila Rajan, Danielle Mandikian, Amos Baruch, et al.Mabs|February 23, 2018
Direct mass spectrometric characterization of disulfide linkagesXiaoyan Guan, Le Zhang, Jette WypychMabs|January 16, 2018
Structure-based engineering to restore high affinity binding of an isoform-selective anti-TGFβ1 antibodyDana M Lord, Julie J Bird, Denise M Honey, et al.Mabs|January 9, 2018
Development and characterization of an anti-rituximab monoclonal antibody panelMinoru Tada, Takuo Suzuki, Akiko Ishii-WatabeMabs|January 10, 2018
Monoclonal antibody higher order structure analysis by high throughput protein conformational arrayYuanli Song, Deqiang Yu, Mukesh Mayani, et al.Mabs|February 6, 2018
A novel bicistronic gene design couples stable cell line selection with a fucose switch in a designer CHO host to produce native and afucosylated glycoform antibodiesGargi Roy, Tom Martin, Arnita Barnes, et al.Mabs|December 12, 2018
Deamidation and isomerization liability analysis of 131 clinical-stage antibodiesXiaojun Lu, R Paul Nobrega, Heather Lynaugh, et al.Pageof 180